1. Drug-eluting and bare metal stents

Biolimus-eluting stents vs Everolimus-eluting stents

NEXT 10 years
Objective
to report the 10-year clinical outcomes of biodegradable polymer biolimus-eluting stents (BP-BES) compared to durable polymer everolimus-eluting stents (DP-EES)
Study
multicentre, non-inferiority randomised trial
Population
patients with stable and unstable angina
Endpoints
10-year TLR and safety endpoint as composite of death or MI
Conclusion
the cumulative adverse 10-year clinical outcomes were not statistically different of treatment with BP-BES compared to DP-EES
Natsuaki et al. EuroIntervention 2023: 19: 100076
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved